These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21996644)

  • 1. Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trial.
    Golubchik P; Sever J; Weizman A
    Clin Neuropharmacol; 2011; 34(6):216-9. PubMed ID: 21996644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder.
    Findling RL; Reed MD; O'Riordan MA; Demeter CA; Stansbrey RJ; McNamara NK
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):792-800. PubMed ID: 16832315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.
    Corson AH; Barkenbus JE; Posey DJ; Stigler KA; McDougle CJ
    J Clin Psychiatry; 2004 Nov; 65(11):1531-6. PubMed ID: 15554768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ; Arvanitis LA; Kowalcyk BB
    J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
    J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 26-week open-label study of quetiapine in children with conduct disorder.
    Findling RL; Reed MD; O'Riordan MA; Demeter CA; Stansbrey RJ; McNamara NK
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):1-9. PubMed ID: 17343549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B; Robert K; László C; Andrea J;
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study.
    Bahk WM; Yoon BH; Lee KU; Chae JH
    Hum Psychopharmacol; 2004 Apr; 19(3):181-5. PubMed ID: 15079852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine in nine youths with autistic disorder.
    Findling RL; McNamara NK; Gracious BL; O'Riordan MA; Reed MD; Demeter C; Blumer JL
    J Child Adolesc Psychopharmacol; 2004; 14(2):287-94. PubMed ID: 15319025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing irritability and aggression in autism spectrum disorders in children and adolescents.
    Robb AS
    Dev Disabil Res Rev; 2010; 16(3):258-64. PubMed ID: 20981764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study.
    Gabriel A
    Clin Ter; 2011; 162(2):113-8. PubMed ID: 21533316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.
    Holzer L; Preuss U; Baumgartner L; Jaugey L; Urben S; Halfon O; Baumann P
    Pharmacopsychiatry; 2011 May; 44(3):87-95. PubMed ID: 21318938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.